Printed from the IBC Life Sciences Web site on May 23, 2013 5:15 PM ET.
Page location: http://www.ibclifesciences.com/CellLine/overview.xml
May 20-22, 2013 · Hyatt Regency La Jolla · San Diego, CA
Coordinated Oscillations in Cortical Actin and Ca(2+) Correlate with Cycles of Vesicle Secretion
Roy Wollman, Ph.D., Assistant Professor, Chemistry and Biochemistry, University of California San Diego
Higher-Faster-Further: Why It Makes Sense to Invest in Innovation to Achieve Disruptive Improvements
Torsten W. Schulz, Ph.D., Director, Cell Culture, Boehringer Ingelheim Fremont, Inc.
Stable Depletion of miR-7 Expression for Improved Performance of a CHO Batch-Fed Culture
Niall Baron, Ph.D., Senior Research Scientist, National Institute for Cellular Biotechnology, Dublin City University, Ireland
Technology Toolbox for Cell Line Development - Towards High Speed, Yield and Clonal Stability
Thomas Jostock, Ph.D., Novartis Leading Scientist, Novartis Pharma AG, Switzerland
Special Discounted Hotel Rate Available Until April 19, 2013. To book your room, call 402-592-6464 or 1-888-421-1442 and mention that you are an IBC attendee at this event.
Consider Attending IBC's Two-Day Intensive Training Course:
Cell Culture and Fermentation Bioprocessing (separate registration required)
East and West Coast Locations:
Join our priority contact list and receive the latest event news.
"Quite worthwhile! Informative, encompassing, broad and yet relevant topics. Great venue for discussion and interaction." - Lynn Davis, Ph.D., Senior Research Biologist, Bend Research Inc.
IBC's Cell Line Development & Engineering conference is driven by the novel approaches and emerging tools that are designed to save you time and money during the process of selecting, developing and engineering your cell lines.
In 3 information packed days, you hear experiences, successes and lessons learned from companies utilizing the rapidly expanding technology toolbox to dramatically improve the speed of cell line development, minimize risk, and increase process and product quality.
"By narrowly targeting the technologies used at the border of R&D of biotherapeutics, this event provides an intensive 3-day review of current, valuable information for this highly specialized group." - Pam Hawley-Nelson, Ph.D., Associate Director, Process Cell Culture, MedImmune
Industry leaders and world-renowned academics share exclusive case studies and unpublished data, providing you with the information required to overcome your toughest challenges and help your company achieve:
"This is an outstanding venue for bringing together experts in the field, vendors, scientists and other interested parties, and the collaborative and open environment has always been rewarding. This meeting is on my calendar every year!" - Gene Lee, Ph.D., Director, Protein and Cell Sciences, EMD Serono